{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:15:12Z","timestamp":1783098912867,"version":"3.54.6"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.mayocp.2022.06.006","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T01:13:57Z","timestamp":1663118037000},"page":"252-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pre-admission and In-Hospital Statin Use is Associated With Reduced Short-Term Mortality in Infective Endocarditis"],"prefix":"10.1016","volume":"98","author":[{"given":"Si-Yeung","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2294-2977","authenticated-orcid":false,"given":"Hang-Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Kei","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Wen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui-Fai","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Fat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory.Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Hang","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"39","key":"10.1016\/j.mayocp.2022.06.006_bib1","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/eurheartj\/ehz620","article-title":"Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study","volume":"40","author":"Habib","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.006_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jama.288.1.75","article-title":"Changing profile of infective endocarditis results of a 1-year survey in France","volume":"288","author":"Hoen","year":"2002","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.mayocp.2022.06.006_bib3","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/CIRCULATIONAHA.119.044913","article-title":"Incidence, microbiology, and outcomes in patients hospitalized with infective endocarditis","volume":"141","author":"Shah","year":"2020","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.mayocp.2022.06.006_bib4","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.jacc.2017.10.005","article-title":"The evolving nature of infective endocarditis in Spain: a population-based study (2003 to 2014)","volume":"70","author":"Olmos","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"44","key":"10.1016\/j.mayocp.2022.06.006_bib5","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.mayocp.2022.06.006_bib6","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.mayocp.2017.07.008","article-title":"Statin use and risk of community-acquired Staphylococcus aureus bacteremia: a population-based case-control study","volume":"92","author":"Smit","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"9508","key":"10.1016\/j.mayocp.2022.06.006_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(06)68041-0","article-title":"Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis","volume":"367","author":"Hackam","year":"2006","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.mayocp.2022.06.006_bib8","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.168.19.2081","article-title":"Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients","volume":"168","author":"Thomsen","year":"2008","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.mayocp.2022.06.006_bib9","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/cid\/cis733","article-title":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes","volume":"55","author":"Mortensen","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.mayocp.2022.06.006_bib10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/mcp.2011.0111","article-title":"Modifiers of symptomatic embolic risk in infective endocarditis","volume":"86","author":"Anavekar","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.006_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.amjcard.2014.03.064","article-title":"Effect of statin therapy on mortality in patients with infective endocarditis","volume":"114","author":"Yang","year":"2014","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.mayocp.2022.06.006_bib12","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1164\/rccm.201812-2328OC","article-title":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial","volume":"200","author":"Sapey","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.mayocp.2022.06.006_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.mayocp.2022.06.006_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/00365548.2014.968608","article-title":"Clinical and economic outcomes of infective endocarditis","volume":"47","author":"Sunder","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.mayocp.2022.06.006_bib15","unstructured":"The Hospital Authority. Hospital authority statistical report 2016-2017. Accessed 15 March 2021. https:\/\/www3.ha.org.hk\/data\/HAStatistics\/DownloadReport\/2"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.006_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.mayocp.2022.06.006_bib17","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1136\/gutjnl-2018-317714","article-title":"Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187,897 patients","volume":"68","author":"Cheung","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.006_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.gastro.2018.03.028","article-title":"Effects of Helicobacter pylori treatment on incidence of gastric cancer in older individuals","volume":"155","author":"Leung","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.mayocp.2022.06.006_bib19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/djy144","article-title":"Metformin use and gastric cancer risk in diabetic patients after Helicobacter pylori eradication","volume":"111","author":"Cheung","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.mayocp.2022.06.006_bib20","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2017.1363","article-title":"Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation","volume":"317","author":"Lau","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mayocp.2022.06.006_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jclinepi.2006.07.011","article-title":"Veteran's affairs hospital discharge databases coded serious bacterial infections accurately","volume":"60","author":"Schneeweiss","year":"2007","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"16","key":"10.1016\/j.mayocp.2022.06.006_bib22","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2017.4287","article-title":"Trends in infective endocarditis in California and New York State, 1998-2013","volume":"317","author":"Toyoda","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mayocp.2022.06.006_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020857","article-title":"Validation of discharge diagnosis codes to identify serious infections among middle age and older adults","volume":"8","author":"Wiese","year":"2018","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.mayocp.2022.06.006_bib24","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/cid\/ciw174","article-title":"Statin use and hospital length of stay among adults hospitalized with community-acquired pneumonia","volume":"62","author":"Havers","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.006_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/rssb.12027","article-title":"Covariate balancing propensity score","volume":"76","author":"Imai","year":"2014","journal-title":"J\u00a0Royal Stat Soc Series B (Stat Methodol)"},{"issue":"6","key":"10.1016\/j.mayocp.2022.06.006_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002584","article-title":"Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: a population-based retrospective cohort study","volume":"15","author":"Verma","year":"2018","journal-title":"PLoS Med"},{"issue":"28","key":"10.1016\/j.mayocp.2022.06.006_bib27","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"7","key":"10.1016\/j.mayocp.2022.06.006_bib28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/aje\/kwq439","article-title":"Doubly robust estimation of causal effects","volume":"173","author":"Funk","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.006_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"key":"10.1016\/j.mayocp.2022.06.006_bib31","series-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2013"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.006_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/biomet\/77.1.147","article-title":"Martingale-based residuals for survival models","volume":"77","author":"Therneau","year":"1990","journal-title":"Biometrika"},{"issue":"4","key":"10.1016\/j.mayocp.2022.06.006_bib33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2022.06.006_bib34","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.chest.2017.09.024","article-title":"A\u00a0population-based cohort study on the drug-specific effect of statins on sepsis outcome","volume":"153","author":"Lee","year":"2018","journal-title":"Chest"},{"issue":"6-7","key":"10.1016\/j.mayocp.2022.06.006_bib35","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/00365540701837357","article-title":"Healthcare associated infective endocarditis: a distinct entity","volume":"40","author":"Siegman-Igra","year":"2008","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2022.06.006_bib36","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1378\/chest.06-2048","article-title":"A\u00a0systematic review of population-based studies of infective endocarditis","volume":"132","author":"Tleyjeh","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.006_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jamaoncol.2017.2752","article-title":"Examining bias in studies of statin treatment and survival in patients with cancer","volume":"4","author":"Emilsson","year":"2018","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.06.006_bib38","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1164\/rccm.201006-0955OC","article-title":"Continuation of statin therapy in patients with presumed infection: a randomized controlled trial","volume":"183","author":"Kruger","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.mayocp.2022.06.006_bib39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1164\/rccm.201209-1718OC","article-title":"A\u00a0multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis","volume":"187","author":"Kruger","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.mayocp.2022.06.006_bib40","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/annrheumdis-2019-215714","article-title":"Diagnosis of osteoporosis in statin-treated patients is dose-dependent","volume":"78","author":"Leutner","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.mayocp.2022.06.006_bib41","article-title":"Time- and dose-dependent association of statin use with risk of clinically relevant new-onset diabetes mellitus in primary prevention: a nationwide observational cohort study","volume":"8","author":"Ko","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.mayocp.2022.06.006_bib42","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1164\/rccm.201302-0392LE","article-title":"Statins for sepsis: distinguishing signal from the noise when designing clinical trials","volume":"188","author":"Patel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.mayocp.2022.06.006_bib43","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1582-4934.2010.01036.x","article-title":"Statins potently reduce the cytokine-mediated IL-6 release in SMC\/MNC cocultures","volume":"15","author":"Loppnow","year":"2011","journal-title":"J\u00a0Cell Mol Med"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.006_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053882","article-title":"A\u00a0clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation","volume":"8","author":"van der Meij","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.mayocp.2022.06.006_bib45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","article-title":"Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis","volume":"164","author":"Harbarth","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mayocp.2022.06.006_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijid.2020.03.009","article-title":"Biomarkers for prediction of mortality in left-sided infective endocarditis","volume":"96","author":"Siciliano","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"15","key":"10.1016\/j.mayocp.2022.06.006_bib47","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.mayocp.2022.06.006_bib48","article-title":"Geographic trends, patient characteristics, and outcomes of infective endocarditis associated with drug abuse in the United States from 2002 to 2016","volume":"8","author":"Kadri","year":"2019","journal-title":"J\u00a0Am Heart Assoc"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622003615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622003615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:39:22Z","timestamp":1758418762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622003615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0025619622003615"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.06.006","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-admission and In-Hospital Statin Use is Associated With Reduced Short-Term Mortality in Infective Endocarditis","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}